Glucose test predicts need for limb loss in diabetics
This article was originally published in Clinica
A simple glucose blood test can predict if a partial foot amputation will succeed in diabetics with foot ulcers or whether a more drastic below knee amputation (BKA) is needed.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.